Firstly, if you are interested in OTC stocks like Astellas Pharma Inc, you will be doing yourself a massive favor by joining the Trader HR chat room (the people there are experts at tricky stocks like this), so do that now – we also strongly recommend Microcap Millionaires where you can learn how to profit hugely off lesser known OTC stocks (what you find there is much more interesting than ALPMY, in our view). These recommendations are current as of 2019-12-04. Now onto the news and analysis.
REPORTING FOR 2019-12-04 | BUNDESPREMIERLEAGUE.COM: We have conducted a deep analysis of how Astellas Pharma Inc (OTCMKTS:ALPMY) has been trading over the last 2 weeks and the past day especially. On its latest session, Astellas Pharma Inc (OTCMKTS:ALPMY) opened at 16.93, reaching a high of 17.27 and a low of 16.93 before closing at a price of 17.16. There was a total volume of 46902.
VOLUME INDICATORS: We saw an accumulation-distribution index of 337.74, an on-balance volume of 17.01, chaikin money flow of 1.0 and a force index of 0.0135. There was an ease of movement rating of 0.00021, a volume-price trend of 2.51294 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.14405, bolinger bands of 17.08314, an upper bollinger band of 16.85686, lower bollinger band of 16.93, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 17.04333, high band keltner channel of 16.70333, low band keltner channel of 17.38333, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 16.93, a donchian channel low band of 16.93, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00179, a MACD signal of 0.001, a MACD difference of 0.0008, a fast Exponential Moving Average (EMA) indicator of 16.93, a slow Exponential Moving Average (EMA) indicator of 16.93, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.14049, a trix of 10.00985, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -2.16259, a KST Oscillator (KST) of 146.4435 and a KST Oscillator (KST Signal) of 146.4435 (leaving a KST difference of 1.35433). We also found an Ichimoku rating of 17.1, an Ichimoku B rating of 17.1, a Ichimoku visual trend A of 15.1324, an Ichimoku visual trend B of 15.63888, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 100.0, a stochastic oscillator of 100.0, a stochastic oscillator signal of 100.0, a Williams %R rating of -533.33333 and an awesome oscillator of -0.009.
RETURNS: There was a daily return of 14.64435, a daily log return of 0.47142 and a cumulative return of 0.47253.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-12-04 (if you are reading this later, the analysis will be out of date), our analysis of technical indicators for Astellas Pharma Inc (OTCMKTS:ALPMY) is telling us that this is ever so slightly bearish. Please comment if you disagree with this conclusion or if you find any errors in the analysis above.
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Astellas Pharma Inc, we strongly advise Astellas Pharma Inc investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on Astellas Pharma Inc and any other stocks you want – without this you are trading blind:
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Astellas Pharma Inc (OTCMKTS:ALPMY) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
I am the driving force behind BPL and a professional daytrader. I will be providing technical analysis of various stocks on BPL.